Clik here to view.
Mesothelioma Study Sees Treatment Possibilities in Flaxseed-derived Compound...
A study reported a potential new treatment for mesothelioma, lignan secoisolariciresinol diglucoside (LGM2605), which prevented cell death as a result of mouse macrophages brought into contact with...
View ArticleClik here to view.
Promising Approach Against Mesothelioma Involves Inhibiting 2 Proteins
Simultaneous inhibition of two proteins, FAK and MDM2, may have therapeutic applications against mesothelioma. A recent study showed that the proteins prevent malignant cells from activating mechanisms...
View ArticleClik here to view.
Preclinical Study Supports Platinum Treatment, Ptac2S, as Promising MPM Therapy
The experimental anti-cancer platinum drug Ptac2S has higher anti-cancer activity than standard of care cisplatin in malignant pleural mesothelioma (MPM) cells, researchers reported, a preclinical...
View ArticleRemoving DNA Modifications in Cancer Cells May Help Decrease Treatment...
Cancer cells often exhibit changes in DNA, called epigenetic modifications, that help tumors progress and resist therapies. In malignant mesothelioma, removing those epigenetic modifications could be...
View ArticleAntiviral, Cidofovir, Seen to Kill Mesothelioma and Other Cancer Cells in...
Treatment with cidofovir, a well-recognized antiviral drug, has shown promise in killing several types of cancer cells, including mesothelioma, data in a preclinical study show. The study, “Reduced...
View ArticleMS Therapy Fingolimod Reduces Mesothelioma Tumor Size in Mice, Study Shows
The multiple sclerosis therapy Fingolimod (FTY720) reduced tumor size in a mouse model of malignant mesothelioma (MM), a study demonstrated. The research, “FTY720 Inhibits Mesothelioma Growth In Vitro...
View ArticleNew Way to Promote Cell Death Could Lead to Better Mesothelioma Therapies,...
Activating a new mechanism to promote cell death could provide hope for better mesothelioma treatments, a Japanese study indicates. The research, ”Connexin 43 enhances Bax activation via JNK activation...
View ArticleWhat’s New in Malignant Mesothelioma Research and Treatment?
According to the American Cancer Society, researchers are constantly studying new ways to treat and possibly prevent mesothelioma. However, there is still a lot to be learned about this disease,...
View ArticleBreast, Ovarian Cancer Therapies Induce Malignant Pleural Mesothelioma Cell...
Tesaro (niraparib) and Lymparza (olaparib) — both PARP1 inhibitors approved by the U.S. Food and Drug Administration to treat breast and ovarian cancer patients — also kill malignant pleural...
View Article
